Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

ProQR Therapeutics N.V. (PRQR) — insider trading: 1 buys, 0 sells · InsiderLens

Home / Companies / ProQR Therapeutics N.V.

ProQR Therapeutics N.V.

PRQR

Insider trading at ProQR Therapeutics N.V.

Transactions on record: 2; since Jun 30, 2026

Insider buys: 1

Insider sells: 0

Active insiders · 12 months: 2; last filing Jun 30, 2026

Figures computed from official regulatory filings — methodology.

Current insiders at ProQR Therapeutics N.V.

Carreno-Gomez BegonaDirector
de Boer Daniel AntonDirector
de Boer Daniel AntonChief Executive Officer
Filius BartDirector
HEGGIE THERESADirector
Hinsch Gylvin LykkeDirector
Hom DennisChief Financial Officer
LAWTON ALISON FRANCISDirector
Maier Martin AlexanderDirector
Platenburg Gerardus JohannesDirector
Platenburg Gerardus JohannesChief Scientific Officer
Shannon James SamuelDirector
Valerio DomenicoDirector

Insider transaction history at ProQR Therapeutics N.V.

Insider	Filed	Type	Qty	Price	Value · USD	Src
Filius Bart	Jun 30, 2026	Buy	150,000	1.54 USD	—	SEC
Hinsch Gylvin Lykke	Jun 30, 2026	AwardD	14,595	0.00 USD	—	SEC